Who Grades the AI Models? | Ben Horowitz & Rayan Krishnan

Who Grades the AI Models? | Ben Horowitz & Rayan Krishnan

a16z’s Erik Torenberg, Ben Horowitz, and Jennifer Li sit down with Vals founder and CEO Rayan Krishnan to discuss one of AI’s increasingly difficult problems: how do you actually measure whether a model is getting better?

As public benchmarks saturate and models get better at optimizing for the tests themselves, Rayan makes the case for independent, continuously evolving evaluations. They unpack why self-reported model scores can be misleading, how VALS evaluates models in the hours before a release, and why measuring increasingly agentic systems means testing work that can unfold over hours, days, or even weeks.

They also explore why evals are becoming critical for enterprises trying to understand the ROI of AI, what happens if token spend begins to rival employee salaries, and how evaluations could eventually provide a shared language for everything from model routing and recursive self-improvement to AI policy and international coordination.


Resources:

Follow Rayan Krishnan on X: https://x.com/RayanKrishnan

Follow Ben Horowitz on X: https://x.com/bhorowitz

Follow Jennifer Li on X: https://x.com/JenniferHli

Stay Updated:

Find a16z on YouTube: YouTube

Find a16z on X

Find a16z on LinkedIn

Listen to the a16z Show on Spotify

Listen to the a16z Show on Apple Podcasts

Follow our host: https://twitter.com/eriktorenberg

Please note that the content here is for informational purposes only; should NOT be taken as legal, business, tax, or investment advice or be used to evaluate any investment or security; and is not directed at any investors or potential investors in any a16z fund. a16z and its affiliates may maintain investments in the companies discussed. For more details please see a16z.com/disclosures.


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(1000)

OpenAI Researchers on the Future of Mathematical Reasoning

OpenAI Researchers on the Future of Mathematical Reasoning

a16z Infra Partner Lisha Li sits down with OpenAI mathematicians Mehtaab Sawhney and Mark Sellke to discuss how quickly AI’s mathematical capabilities are advancing, what recent results reveal about m...

8 Syys 1h 5min

Can Open Source Keep AI Power From Concentrating?

Can Open Source Keep AI Power From Concentrating?

MTS host Sophia Dew visits the Open Source AI Summit in San Francisco to ask researchers and founders across the AI stack a central question: can open source prevent AI power from concentrating in the...

7 Syys 8min

Your AI Doctor Is Coming | Julie Yoo

Your AI Doctor Is Coming | Julie Yoo

a16z General Partner Julie Yoo joins MTS host Sophia Dew to explain why she believes healthcare could benefit more from AI than almost any other industry, and why decades of slow technology adoption m...

6 Syys 27min

Aaron Levie on Why Open AI Wins

Aaron Levie on Why Open AI Wins

Box co-founder and CEO Aaron Levie joins MTS hosts Theo Jaffee and Sofia Puccini to make the case for open-weight AI, unpack the economics of open versus closed models, and explain why he believes mor...

5 Syys 31min

Fei Fei Li: The Race to Build World Models For AI

Fei Fei Li: The Race to Build World Models For AI

World Labs co-founders Fei-Fei Li, Justin Johnson, and Ben Mildenhall join a16z General Partner Martin Casado to discuss Atlas, their latest world model, and what it reveals about the pursuit of spati...

4 Syys 44min

The $100B Niches Hiding Inside Payments

The $100B Niches Hiding Inside Payments

Erik Torenberg is joined by a16z General Partner Alex Rampell and Affirm Co-Founder and CEO Max Levchin for a conversation on 25 years of fintech, from the early days of digital payments to the origin...

3 Syys 1h

Inside Moderna’s Personalized Cancer Vaccine

Inside Moderna’s Personalized Cancer Vaccine

a16z General Partner Jorge Conde sits down with Moderna CEO Stéphane Bancel to discuss a major milestone for mRNA technology: positive Phase 3 results from Moderna and Merck’s individualized treatment...

2 Syys 40min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
vallattomat
psykopodiaa-podcast
rss-rahapodi
mimmit-sijoittaa
lakicast
ostan-asuntoja-podcast
rss-sami-miettinen-neuvottelija
rss-rahamania
hyva-paha-johtaminen
rss-karon-grilli
sijoituskaverit
rss-lahtijat
rss-startup-ministerio
rss-paasipodi
rss-oivalluksia-rahasta-elamasta
leadcast
rss-avaimet-menestykseen
pomojen-suusta
rss-yhteyden-ytimessa